Serum Biomarkers for the Diagnosis of Glaucoma

Shin, Young Joo and Kim, Eunbi and Han, Bobby Kwanghoon and Yi, Kayoung (2020) Serum Biomarkers for the Diagnosis of Glaucoma. Diagnostics, 11 (1). p. 20. ISSN 2075-4418

[thumbnail of diagnostics-11-00020-v2.pdf] Text
diagnostics-11-00020-v2.pdf - Published Version

Download (2MB)

Abstract

Despite the importance of the early detection of glaucoma, most patients with progressive glaucoma show minimal symptoms. We aimed to evaluate biomarkers for glaucoma diagnosis in Korea. Forty-two volunteers with/without open-angle glaucoma were enrolled from January through October 2015—divided into a control or open-angle glaucoma group, which was further divided into normal-tension glaucoma (NTG) and high-tension glaucoma (HTG) groups—and underwent assessments for myelin basic protein (MBP), heat shock protein 60, anti-Sjögren’s-syndrome-related antigen A (SSA) and antigen B (SSB), anti-α-fodrin, and anti-nucleic acid. The glaucoma group showed a higher serum MBP level and lower serum anti-α-fodrin antibody level than the control group (p < 0.05). The NTG group showed higher serum anti-SSA and anti-SSB levels and lower anti-α-fodrin IgG/IgA levels than the HTG group. In the receiver operating characteristic curve analysis, the area under the curve (AUC) for serum MBP level was 0.917 in discriminating between controls and patients with glaucoma. Between the NTG and HTG groups, anti-SSA, anti-SSB, and anti-α-fodrin IgG/IgA levels showed an AUC above 0.8. Thus, these biomarkers were useful for diagnosing glaucoma and discriminating between controls and patients with glaucoma, and patients with NTG and HTG.

Item Type: Article
Subjects: Journal Eprints > Medical Science
Depositing User: Managing Editor
Date Deposited: 24 Feb 2023 05:53
Last Modified: 23 May 2024 05:46
URI: http://repository.journal4submission.com/id/eprint/540

Actions (login required)

View Item
View Item